Crossref
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations
Nucleic Acid Therapeutics · 01.12.2024 · 34 (6) · 273-275
DOI: 10.1089/nat.2024.0060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, online erschienen am 09.12.2024. Verfasst von Stanley T Crooke. Beteiligte Einrichtung: n-Lorem Foundation, Carlsbad, California, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- n-Lorem Foundation, Carlsbad, California, USA.
Zitieren
APA
Crooke, S. T. (2024). Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations. Nucleic Acid Therapeutics, 34(6), 273-275. https://doi.org/10.1089/nat.2024.0060
Vancouver
Crooke ST. Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations. Nucleic Acid Therapeutics. 2024;34(6):273-275. doi:10.1089/nat.2024.0060
BibTeX
@article{Crooke2024,
author = {Crooke, Stanley T},
title = {Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations},
journal = {Nucleic Acid Therapeutics},
year = {2024},
volume = {34},
number = {6},
pages = {273--275},
doi = {10.1089/nat.2024.0060}
}
EUVIMED